Free Trial

Pacific Biosciences of California (PACB) SEC Filings & 10K Form

$1.82
-0.22 (-10.76%)
(As of 09/20/2024 ET)

Recent Pacific Biosciences of California SEC Filings

DateFilerForm TypeView
09/16/2024
4:40 PM
HENRY CHRISTIAN O (Reporting)
Pacific Biosciences of California (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
4:25 PM
Pacific Biosciences of California (Issuer)
Van Oene Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
4:27 PM
Eidel Jeff (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:29 PM
Pacific Biosciences of California (Subject)
Van Oene Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2024
7:46 PM
Pacific Biosciences of California (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/20/2024
4:00 PM
MOHR MARSHALL (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:02 PM
ORDONEZ KATHY (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:03 PM
Pacific Biosciences of California (Issuer)
Shapiro Lucy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:04 PM
Pacific Biosciences of California (Issuer)
Valantine Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:52 PM
Ericson William W. (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:53 PM
LIVINGSTON RANDALL S (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:56 PM
Meline David W (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:44 PM
Pacific Biosciences of California (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/29/2024
8:52 PM
Pacific Biosciences of California (Filer)
Form DEFA14A
05/22/2024
4:25 PM
Farmer Michele (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:21 PM
Pacific Biosciences of California (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
7:16 AM
Pacific Biosciences of California (Filer)
Form DEF 14A
04/29/2024
7:17 AM
Pacific Biosciences of California (Filer)
Form DEFA14A
04/29/2024
7:19 AM
Pacific Biosciences of California (Filer)
Form ARS
04/16/2024
7:08 AM
Pacific Biosciences of California (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
7:17 AM
Pacific Biosciences of California (Filer)
Form PRE 14A
04/11/2024
4:00 PM
Pacific Biosciences of California (Filer)
Form POSASR
04/11/2024
4:02 PM
Pacific Biosciences of California (Filer)
Form POSASR
04/11/2024
4:02 PM
Pacific Biosciences of California (Filer)
Form POSASR
03/06/2024
4:26 PM
Pacific Biosciences of California (Issuer)
Van Oene Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:30 PM
Farmer Michele (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:36 PM
Meline David W (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:12 PM
HENRY CHRISTIAN O (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:22 PM
Kim Susan G. (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:27 PM
MOHR MARSHALL (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:22 PM
Pacific Biosciences of California (Subject)
Van Oene Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
5:32 PM
Kim Susan G. (Reporting)
Pacific Biosciences of California (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:36 PM
Kim Susan G. (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
3:19 PM
Farmer Michele (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:07 PM
Farmer Michele (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:14 PM
HENRY CHRISTIAN O (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:17 PM
Kim Susan G. (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:20 PM
Eidel Jeff (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:25 PM
Pacific Biosciences of California (Issuer)
Van Oene Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
3:16 PM
HENRY CHRISTIAN O (Reporting)
Pacific Biosciences of California (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
3:17 PM
Kim Susan G. (Reporting)
Pacific Biosciences of California (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
How the US Will Win the Great Lithium Race (Ad)

China spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but it processes 70-80%. Now the US is coming over the top by investing $700B+ into domestic supply with the IRA and Bi-partisan Infrastructure Bill.

Join GM as an early investor in this company by October 3.
02/16/2024
4:52 PM
Eidel Jeff (Reporting)
Pacific Biosciences of California (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
4:54 PM
Pacific Biosciences of California (Subject)
Van Oene Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
4:38 PM
HENRY CHRISTIAN O (Reporting)
Pacific Biosciences of California (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
4:12 PM
Nikko Asset Management Americas, Inc. (Filed by)
Pacific Biosciences of California (Subject)
Form SC 13G/A
02/09/2024
5:42 AM
Jackson Square Partners, LLC (Filed by)
Pacific Biosciences of California (Subject)
Form SC 13G/A
02/05/2024
5:08 AM
Pacific Biosciences of California (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
01/29/2024
3:01 PM
ARK Investment Management LLC (Filed by)
Pacific Biosciences of California (Subject)
Form SC 13G/A
01/10/2024
4:44 PM
Pacific Biosciences of California (Issuer)
Van Oene Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
9:16 AM
Pacific Biosciences of California (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/09/2024
3:26 PM
Pacific Biosciences of California (Subject)
Van Oene Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:03 AM
Pacific Biosciences of California (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
3:35 PM
HENRY CHRISTIAN O (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:34 PM
HENRY CHRISTIAN O (Reporting)
Pacific Biosciences of California (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
7:06 AM
Pacific Biosciences of California (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
3:06 PM
Pacific Biosciences of California (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2023
4:00 PM
Pacific Biosciences of California (Filer)
Form 8-K/A
10/19/2023
3:10 PM
Pacific Biosciences of California (Filer)
Form D
Notice of Exempt Offering of Securities 
10/16/2023
7:08 AM
Pacific Biosciences of California (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
7:12 AM
Meline David W (Reporting)
Pacific Biosciences of California (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2023
7:15 AM
Meline David W (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
5:47 PM
Kim Susan G. (Reporting)
Pacific Biosciences of California (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
3:48 PM
Kim Susan G. (Reporting)
Pacific Biosciences of California (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PACB) was last updated on 9/20/2024 by MarketBeat.com Staff
From Our Partners